Page last updated: 2024-10-23

benfluorex and Cardiomyopathy, Restrictive

benfluorex has been researched along with Cardiomyopathy, Restrictive in 1 studies

Cardiomyopathy, Restrictive: A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tribouilloy, C1
Rusinaru, D1
Henon, P1
Tribouilloy, L1
Leleu, F1
Andréjak, M1
Sevestre, H1
Peltier, M1
Caus, T1

Other Studies

1 other study available for benfluorex and Cardiomyopathy, Restrictive

ArticleYear
Restrictive organic mitral regurgitation associated with benfluorex therapy.
    European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2010, Volume: 11, Issue:7

    Topics: Aged; Appetite Depressants; Body Mass Index; Cardiomyopathy, Restrictive; Diabetes Mellitus; Drug Th

2010